Skip to content

Clinical trials

Phase 2 Carcinoma, Ovarian Epithelial trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 2 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20073
20101
20132
20141
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group3
SOTIO a.s.2
AGO Research GmbH1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
JSehouli1
Morphotek1
Neovii Biotech1
TORL Biotherapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial12
Ovarian Neoplasms5
Fallopian Tube Neoplasms3
Neoplasms2
Ataxia Telangiectasia1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Congenital Abnormalities1
Hodgkin Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.